Difference in Clinical Patterns between COVID-19 Affected Children and Adults

F Hasnat1, F Noman, A L Moben

  • 1Dr Ferdousi Hasnat, Assistant Professor (Paediatrics), Kurmitola General Hospital, Dhaka Cantonment, Bangladesh;

Insights

Children infected with coronavirus (COVID-19) experience milder symptoms and fewer severe cases compared to adults. This study highlights significant differences in clinical presentation and laboratory findings between pediatric and adult COVID-19 patients.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Epidemiology

Background:

  • Coronavirus disease (COVID-19) emerged as a global health crisis in December 2019.
  • While all age groups are affected, initial observations suggested milder disease in children.
  • Understanding clinical differences between pediatric and adult COVID-19 cases is crucial for effective management.

Purpose of the Study:

  • To compare the clinical patterns and laboratory findings of COVID-19 in children and adults.
  • To identify key differences in disease severity and symptom presentation between pediatric and adult populations.

Main Methods:

  • A cross-sectional prospective study conducted at Kurmitola General Hospital, Dhaka, from April to September 2020.
  • 150 COVID-19 positive patients (50 children aged 1-18 years, 100 adults >18 years) were enrolled.
  • Clinical symptoms, laboratory results, and chest X-ray findings were analyzed and compared between the two groups.

Main Results:

  • Fever and cough were common in both groups, but fever was significantly more prevalent in adults (81%) than children (36%).
  • No severe or critical cases were observed in children; most presented with mild (68%) or moderate (24%) illness.
  • Adults exhibited a higher incidence of moderate (72%), severe (14%), and critical (5%) cases, along with more frequent leukopenia, lymphopenia, elevated CRP, and ferritin levels. Pneumonia was also more common in adults (83%) than children (42%).

Conclusions:

  • Coronavirus affects children, but their clinical presentation is generally milder than in adults.
  • Significant differences exist in symptom prevalence, disease severity, laboratory findings, and radiographic evidence of pneumonia between pediatric and adult COVID-19 patients.
  • These findings underscore the need for age-specific considerations in the diagnosis and management of COVID-19.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
36
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
34
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
43
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
696
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
35